193 related articles for article (PubMed ID: 19289468)
1. MADD, a splice variant of IG20, is indispensable for MAPK activation and protection against apoptosis upon tumor necrosis factor-alpha treatment.
Kurada BRVVSN; Li LC; Mulherkar N; Subramanian M; Prasad KV; Prabhakar BS
J Biol Chem; 2009 May; 284(20):13533-13541. PubMed ID: 19289468
[TBL] [Abstract][Full Text] [Related]
2. Contrasting effects of IG20 and its splice isoforms, MADD and DENN-SV, on tumor necrosis factor alpha-induced apoptosis and activation of caspase-8 and -3.
Al-Zoubi AM; Efimova EV; Kaithamana S; Martinez O; El-Idrissi Mel-A; Dogan RE; Prabhakar BS
J Biol Chem; 2001 Dec; 276(50):47202-11. PubMed ID: 11577081
[TBL] [Abstract][Full Text] [Related]
3. Down-modulation of expression, or dephosphorylation, of IG20/MADD in tumor necrosis factor-related apoptosis-inducing ligand-resistant thyroid cancer cells makes them susceptible to treatment with this ligand.
Li LC; Jayarama S; Pilli T; Qian L; Pacini F; Prabhakar BS
Thyroid; 2013 Jan; 23(1):70-8. PubMed ID: 22998497
[TBL] [Abstract][Full Text] [Related]
4. MADD/DENN splice variant of the IG20 gene is necessary and sufficient for cancer cell survival.
Mulherkar N; Ramaswamy M; Mordi DC; Prabhakar BS
Oncogene; 2006 Oct; 25(47):6252-61. PubMed ID: 16682944
[TBL] [Abstract][Full Text] [Related]
5. IG20, in contrast to DENN-SV, (MADD splice variants) suppresses tumor cell survival, and enhances their susceptibility to apoptosis and cancer drugs.
Efimova EV; Al-Zoubi AM; Martinez O; Kaithamana S; Lu S; Arima T; Prabhakar BS
Oncogene; 2004 Feb; 23(5):1076-87. PubMed ID: 14716293
[TBL] [Abstract][Full Text] [Related]
6. MADD/DENN splice variant of the IG20 gene is a negative regulator of caspase-8 activation. Knockdown enhances TRAIL-induced apoptosis of cancer cells.
Mulherkar N; Prasad KV; Prabhakar BS
J Biol Chem; 2007 Apr; 282(16):11715-21. PubMed ID: 17314102
[TBL] [Abstract][Full Text] [Related]
7. IG20 (MADD splice variant-5), a proapoptotic protein, interacts with DR4/DR5 and enhances TRAIL-induced apoptosis by increasing recruitment of FADD and caspase-8 to the DISC.
Ramaswamy M; Efimova EV; Martinez O; Mulherkar NU; Singh SP; Prabhakar BS
Oncogene; 2004 Aug; 23(36):6083-94. PubMed ID: 15208670
[TBL] [Abstract][Full Text] [Related]
8. miR-181 interacts with signaling adaptor molecule DENN/MADD and enhances TNF-induced cell death.
Ghorbani S; Talebi F; Ghasemi S; Jahanbazi Jahan Abad A; Vojgani M; Noorbakhsh F
PLoS One; 2017; 12(3):e0174368. PubMed ID: 28323882
[TBL] [Abstract][Full Text] [Related]
9. IG20, a MADD splice variant, increases cell susceptibility to gamma-irradiation and induces soluble mediators that suppress tumor cell growth.
Efimova E; Martinez O; Lokshin A; Arima T; Prabhakar BS
Cancer Res; 2003 Dec; 63(24):8768-76. PubMed ID: 14695193
[TBL] [Abstract][Full Text] [Related]
10. Regulation of apoptosis and caspase-8 expression in neuroblastoma cells by isoforms of the IG20 gene.
Li LC; Sheng JR; Mulherkar N; Prabhakar BS; Meriggioli MN
Cancer Res; 2008 Sep; 68(18):7352-61. PubMed ID: 18794122
[TBL] [Abstract][Full Text] [Related]
11. DENN/MADD/IG20 alternative splicing changes and cell death in Alzheimer's disease.
Mo Y; Williams C; Miller CA
J Mol Neurosci; 2012 Sep; 48(1):97-110. PubMed ID: 22678883
[TBL] [Abstract][Full Text] [Related]
12. Brefeldin A-Inhibited Guanine Nucleotide-Exchange Factor 1 (BIG1) Governs the Recruitment of Tumor Necrosis Factor Receptor-Associated Factor 2 (TRAF2) to Tumor Necrosis Factor Receptor 1 (TNFR1) Signaling Complexes.
Noguchi T; Tsuchida M; Kogue Y; Spadini C; Hirata Y; Matsuzawa A
Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27834853
[TBL] [Abstract][Full Text] [Related]
13. IG20/MADD plays a critical role in glucose-induced insulin secretion.
Li LC; Wang Y; Carr R; Haddad CS; Li Z; Qian L; Oberholzer J; Maker AV; Wang Q; Prabhakar BS
Diabetes; 2014 May; 63(5):1612-23. PubMed ID: 24379354
[TBL] [Abstract][Full Text] [Related]
14. Knockdown of IG20 gene expression renders thyroid cancer cells susceptible to apoptosis.
Subramanian M; Pilli T; Bhattacharya P; Pacini F; Nikiforov YE; Kanteti PV; Prabhakar BS
J Clin Endocrinol Metab; 2009 Apr; 94(4):1467-71. PubMed ID: 19190106
[TBL] [Abstract][Full Text] [Related]
15. SUMOylation of Grb2 enhances the ERK activity by increasing its binding with Sos1.
Qu Y; Chen Q; Lai X; Zhu C; Chen C; Zhao X; Deng R; Xu M; Yuan H; Wang Y; Yu J; Huang J
Mol Cancer; 2014 Apr; 13():95. PubMed ID: 24775912
[TBL] [Abstract][Full Text] [Related]
16. Akt-phosphorylated mitogen-activated kinase-activating death domain protein (MADD) inhibits TRAIL-induced apoptosis by blocking Fas-associated death domain (FADD) association with death receptor 4.
Li P; Jayarama S; Ganesh L; Mordi D; Carr R; Kanteti P; Hay N; Prabhakar BS
J Biol Chem; 2010 Jul; 285(29):22713-22. PubMed ID: 20484047
[TBL] [Abstract][Full Text] [Related]
17. MADD is a downstream target of PTEN in triggering apoptosis.
Jayarama S; Li LC; Ganesh L; Mardi D; Kanteti P; Hay N; Li P; Prabhakar BS
J Cell Biochem; 2014 Feb; 115(2):261-70. PubMed ID: 24038283
[TBL] [Abstract][Full Text] [Related]
18. MADD Expression in Lung Adenocarcinoma and its Impact on Proliferation and Apoptosis of Lung Adenocarcinoma Cells.
Ye B; Zhong F; Yu G; Lou H; Hu J
Comb Chem High Throughput Screen; 2019; 22(3):207-215. PubMed ID: 30947659
[TBL] [Abstract][Full Text] [Related]
19. [Expression of MADD in lung adenocarcinoma tissues and its effects on proliferation and apoptosis of lung adenocarcinoma A549 cells].
Wei YP; Wu JX; Guo YF; Sun GY; Zhang Q; Bi WX; Dong L
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Apr; 28(4):354-7. PubMed ID: 22482404
[TBL] [Abstract][Full Text] [Related]
20. Down-regulation of DENN/MADD, a TNF receptor binding protein, correlates with neuronal cell death in Alzheimer's disease brain and hippocampal neurons.
Del Villar K; Miller CA
Proc Natl Acad Sci U S A; 2004 Mar; 101(12):4210-5. PubMed ID: 15007167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
